Contact Us

Please leave a message

×

  • DKSH Acquires Taqkey Science and Quantum Biotech

  • DKSH Reports Strong Core EBIT Growth in Its Full-Year Results 2024

  • Sustainability Report 2024

    DKSH Makes Meaningful Progress Across All Its Four Sustainability Objectives

Industries we serve globally Explore our Business Units

Key topics of interest

Insights

Insights

Get the latest insights from our experts as well as stories of where we have made an impact for our business partners.

Sustainability

Sustainability

Read our latest stories, annual reports and learn more about our approach to sustainability.

Women At DKSH

Women at DKSH

Meet some of the great women working at DKSH today.

Did you know that...?

DKSH facts and figures 2024

News

DKSH’s 92nd Annual General Meeting 2025

Shareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors, and appointment of a new Board member Proposal of dividend increase of 4.4% to CHF 2.35 per share accepted

DKSH Technology Strengthens its Korean Business with the Acquisition of MDxK

DKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (“MDxK”), a well- established player in the South-Korean life-science space. With this transaction, DKSH Technology further extends its scientific solutions business in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

DKSH Technology Acquires Taqkey Science and Quantum Biotech, Two Technology Distribution Companies in Taiwan

DKSH has signed an agreement to acquire Taqkey Science (“Taqkey”) and Quantum Biotech (“Quantum”) in Taiwan. With these transactions, DKSH Technology further extends its scientific solutions and consumables businesses in line with the Business Units’ strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

Select a market